Associated Papers
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer.
Kindt CK et al.
International Journal of Cancer, 2024
39128978 (PubMed )
Supplement: supplement_1.pdf
Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J et al.
Plos One, 2018
29649263 (PubMed )
Supplement: pone.0195761.s003.xlsx › S3
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM et al.
Bmc Cancer, 2017
Select a paper to view details